1. All
  2. Press Releases
  3. Events
  4. Publications

Primo Biotech’s Innovative Radiopharmaceutical Enrolls First Patient, Marking a New Milestone in Precision Medicine for Colorectal Cancer

Press Releases

Radium-223’s Impact on Skeletal Events in Metastatic Castration-Resistant Prostate Cancer: A Meta-Analysis

Publications

Cost-Utility Analysis of 18F-FDG Imaging: A Network Meta-Analysis of Diagnostic Modalities

Publications

Advancing Early Detection: PSMA PET and Biomarkers Redefine Prostate Cancer Diagnosis

Press Releases

Sincerely Inviting You to A New Era in Prostate Cancer Diagnosis — Nuclear Medicine Driving Clinical Breakthroughs

Events

Primo Goes Global: Radioligand Theranostics Take the Stage at AACR on Campus

Events

Primo Shines at the 2025 Annual Conference of TSNM, showcasing Breakthrough Innovations

Events

Radiopharmaceuticals: New Drug Development Process and the Importance of Preclinical Research

Publications

Procedures for GMP-Compliant Production of [¹⁷⁷Lu]Lu-PSMA-I&T, Quality Control, and Evaluation of Stability Over Five Days

Publications

First Automated Radiosynthesis of [161Tb]Tb-PSMA-I&T in Taiwan Using the iPHASE MultiSyn Synthesizer

Publications

Primo Biotechnology and Anbogen Therapeutics Forge Strategic Collaboration to Co-Develop Precision Radioligand for Solid Tumors Diagnosis and Therapy

Press Releases

Primo Biotechnology and Terthera B.V. Announce Strategic Partnership to Advance Terbium-161 Radioligand Therapies in Taiwan

Press Releases